Nikki Hafezi’s recent visit to Tashkent’s School No.178, the first public school in Uzbekistan to join the K-MAP study, emphasized the importance of keratoconus prevalence research and the inspiring potential of youth. Her engagement highlights the vital link between education and health initiatives.
Discover the latest advancements in keratoconus treatment with the ELZA Institute’s innovative techniques: transPRK, PACE, and All Femto-CAIRS, as featured in The Ophthalmologist.
The “Schweizerischen Ärztezeitung” (the Swiss Medical Journal) recently reported on ELZA’s consultant glaucoma surgeon, Prof. Dr. med. Kaweh Mansouri’s appointment as the Executive Vice President of the World Glaucoma Association (WGA) in an article titled “He fights against glaucoma”. This appointment marks the first time a Swiss and European specialist has been elected to this position within the WGA.
ELZA contributed to the recent 2024 SAoO Annual Congress, held in Lucerne, Switzerland, with Prof. Farhad Hafezi giving multiple lectures and co-leading the Refractive Surgery Course.
In a recent publication in “Ophta,” Dr. Emilio Torres-Netto, Prof. Dr. Farhad Hafezi, and Dr. Mark Hillen present a review on the application of a well-established antihypertensive medication, losartan, for treating corneal opacities.
Join Dr. Emilio Torres-Netto at the Von Hoff event during SAoO 2024 in Lucerne for a groundbreaking presentation on Cataract Surgery for Irregular Corneas
ELZA was represented at the 86th SBAO Symposium in Bern held last weekend by our Consultant Oculoplastic surgeon, Dr. Dr. Dion Paridaens.
Our CEO’s keratoconus screening in Uzbekistan underscores the importance of early detection and treatment, in collaboration with local medical professionals.
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
